The a2 Milk Co Ltd (ASX: A2M) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
The a2 Milk Co Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
The a2 Milk Co Ltd (ASX: A2M)
Latest News
Growth Shares
Why I would buy a2 Milk Company and these ASX growth shares
Growth Shares
3 ASX growth shares to buy and hold for the next decade
Share Market News
3 ASX growth shares to buy and hold beyond 2025
Growth Shares
2 of the best ASX growth shares to buy for 2020
Share Market News
Forget a2 Milk! Why these 3 ASX baby formula stocks could soar in 2020
Growth Shares
Where to invest $10,000 in ASX shares right now
Share Market News
ALL ORDINARIES finishes lower Monday: 8 ASX shares you missed
Share Gainers
2 ASX shares exposed to China's growth
Share Market News
A2 Milk Company announces more senior leadership changes
Share Gainers
Is this infant formula company the next a2 Milk Company?
How to invest
ASX industries to include in your portfolio for diversification
Growth Shares
3 stellar ASX growth shares to buy in January
Frequently Asked Questions
-
The a2 Milk Company Ltd paid its maiden dividend to shareholders in April 2025.
-
The a2 Milk Company Ltd does not currently have a dividend reinvestment program.
-
The company was founded in 2000 in New Zealand and listed on the ASX in March 2015.
Dividend Payment History Data provided by Morningstar.
| Ex-Date | Amount | Franking | Type | Payable |
|---|---|---|---|---|
| 18 Sep 2025 | $0.1150 | 0.00% | Final | 03 Oct 2025 |
| 20 Mar 2025 | $0.0650 | 0.00% | Interim | 04 Apr 2025 |
A2M ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About The a2 Milk Co Ltd
A2 Milk Company Ltd (ASX: A2M) is a fresh milk and infant formula company that sources, produces and supplies a2 brand milk and milk-related products in Australia and globally.
The Company was founded in 2000 in New Zealand by scientist Dr Corran McLachlan and Howard Paterson.
The company produces fresh cows' milk that naturally contains the A2 protein type and no A1 protein. Some research suggests the A1 protein can cause digestion issues.
A2M Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 13 Jan 2026 | $9.20 | $0.06 | 0.66% | 1,880,809 | $9.19 | $9.24 | $9.13 |
| 12 Jan 2026 | $9.14 | $-0.04 | -0.44% | 1,888,747 | $9.18 | $9.21 | $9.11 |
| 09 Jan 2026 | $9.18 | $0.02 | 0.22% | 650,003 | $9.19 | $9.28 | $9.17 |
| 08 Jan 2026 | $9.16 | $0.09 | 0.99% | 1,028,591 | $9.01 | $9.22 | $9.01 |
| 07 Jan 2026 | $9.07 | $0.02 | 0.22% | 707,059 | $9.02 | $9.15 | $9.00 |
| 06 Jan 2026 | $9.05 | $-0.19 | -2.06% | 961,096 | $9.24 | $9.28 | $9.05 |
| 05 Jan 2026 | $9.24 | $0.06 | 0.65% | 550,132 | $9.20 | $9.32 | $9.17 |
| 02 Jan 2026 | $9.18 | $-0.03 | -0.33% | 364,890 | $9.20 | $9.28 | $9.18 |
| 31 Dec 2025 | $9.21 | $-0.11 | -1.18% | 391,601 | $9.22 | $9.34 | $9.18 |
| 30 Dec 2025 | $9.32 | $0.12 | 1.30% | 379,752 | $9.25 | $9.33 | $9.21 |
| 29 Dec 2025 | $9.20 | $-0.05 | -0.54% | 545,052 | $9.25 | $9.25 | $9.17 |
| 24 Dec 2025 | $9.25 | $0.02 | 0.22% | 382,714 | $9.16 | $9.28 | $9.16 |
| 23 Dec 2025 | $9.23 | $0.04 | 0.44% | 716,392 | $9.19 | $9.31 | $9.15 |
| 22 Dec 2025 | $9.19 | $0.15 | 1.66% | 1,756,071 | $9.02 | $9.29 | $9.01 |
| 19 Dec 2025 | $9.04 | $0.11 | 1.23% | 2,381,610 | $8.95 | $9.04 | $8.87 |
| 18 Dec 2025 | $8.93 | $-0.12 | -1.33% | 1,792,819 | $8.92 | $9.01 | $8.86 |
| 17 Dec 2025 | $9.05 | $-0.15 | -1.63% | 980,344 | $9.20 | $9.25 | $9.05 |
| 16 Dec 2025 | $9.20 | $0.16 | 1.77% | 1,335,737 | $9.00 | $9.26 | $8.99 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 08 Dec 2025 | David Bortolussi | Issued | 324,606 | $2,940,930 |
Issue of securities. 1,553,008 performance rights
|
| 26 Nov 2025 | David Bortolussi | Sell | 245,453 | $2,672,983 |
On-market trade. NZD
|
| 26 Sep 2025 | Kathryn(Kate) Mitchell | Buy | 2,184 | $20,748 |
On-market trade. NZD
|
| 24 Sep 2025 | Kathryn(Kate) Mitchell | Buy | 816 | $7,752 |
On-market trade. NZD
|
| 23 Sep 2025 | Kathryn(Kate) Mitchell | Buy | 3,000 | $28,350 |
On-market trade. NZD
|
| 15 Sep 2025 | David Bortolussi | Sell | 242,345 | $2,484,036 |
On-market trade. NZD
|
| 26 Aug 2025 | David Bortolussi | Buy | 484,691 | $4,444,616 |
Conversion of securities.
|
| 26 Aug 2025 | David Bortolussi | Expiry | 16,489 | $151,204 |
As advised by the company. Lapsed, 17,13,093 Rights
|
| 26 Aug 2025 | David Bortolussi | Exercise | 484,691 | $4,444,616 |
Conversion of securities. 12,28,402 Rights
|
| 21 Aug 2025 | Kathryn(Kate) Mitchell | Buy | 2,500 | $24,050 |
On-market trade. NZD
|
| 20 Aug 2025 | Kathryn(Kate) Mitchell | Buy | 5,500 | $51,755 |
On-market trade. NZD
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr David Landt Bortolussi | Chief Executive OfficerManaging Director | Feb 2021 |
Mr Bortolussi, prior to joining the Company, held the role of Group President, HanesBrands, and prior to that he was the CEO of Pacific Brands. In 2016, HanesBrands acquired Pacific Brands and expanded David's role to cover international innerwear operations outside of the Americas. Prior to this, David was the Chief Strategy Officer at Foster's Group and held senior consulting roles at McKinsey & Company and PwC. David's career has been focused on the consumer and retail sector in Australia and New Zealand complemented by international experience in markets and categories in China, SE Asia, EU, UK and the USA. David also has an interest in private equity and growth-phase businesses. He is a member of the advisory board of Whiteoak and supports the development of investee companies.
|
| Ms Philippa (Pip) Mary Greenwood | Non-Executive ChairmanNon-Executive Director | Jul 2019 |
Ms Greenwood is currently the Chair of Westpac New Zealand and a director of Fisher & Paykel Healthcare and Westpac Banking Corporation. She was previously a director of Spark New Zealand and Vulcan Steel. Prior to becoming a full time director, Pip was a senior partner at law firm Russell McVeagh, where she spent over 10 years on the firm's Board including acting as the firm's Board Chair and interim CEO. Pip brings commercial and board experience to The a2 Milk Company Board. She is member of People Committee.
|
| Ms Kathryn(Kate) Mitchell | Non-Executive Director | Jun 2023 |
Ms Mitchell has governance experience as a director of both private and public companies. She is also skilled in the areas of financial risk management, structured financing and investments. Kate is currently Chair of The New Zealand Merino Company and Link Engine Management. She is also a director of Christchurch International Airport, where she chairs the Property and Commercial Committee. Prior to moving to New Zealand in 2014, Kate's executive career spanned 20 years in investment banking in London, which included senior leadership roles in Global Markets at Deutsche Bank, Goldman Sachs and Merrill Lynch. She is also Chair of the Risk Management Committee.
|
| Ms Sandra Yu | Non-Executive Director | Mar 2022 |
Ms Yu is a company director and an experienced global executive in consumer goods industries, and importantly in the IMF market in China, with a proven track record of driving business and brand transformation, leveraging opportunities for growth, and building organisational capabilities across China as well as the USA and other parts of Asia. She is currently a director of 91AAP Inc, a retail Software as a Service provider. As the former head of Mead Johnson Nutrition's Greater China business, Sandra was a member of the Mead Johnson Nutrition's Global leadership team. Prior to that, Sandra held other senior executive roles at Mead Johnson Nutrition, including as the Global Marketing Vice President, responsible for transition to new digital media and e-commerce channels globally. Sandra was also appointed as the non-executive chairwoman to lead RB China Advisory Board after the merger between Reckitt Benckiser and Mead Johnson Nutrition in 2017. Prior to joining Mead Johnson, Sandra held executive positions at Unilever, where she worked across Asia for 13 years. Sandra is the Chair of the People Committee and member of Risk Management Committee.
|
| Mr Grant Andrew Dempsey | Non-Executive Director | Sep 2025 |
Mr Dempsey brings financial, strategic and commercial experience to the Board through his career in investment banking and CFO roles held at ASX50 listed companies. Grant commenced his career as an auditor before spending time in business development at Bank of Melbourne and General Electric. Grant then gained experience in investment banking, initially at UBS and Citi, then at JP Morgan for 10 years, including as its Head of Banking. Following this, Grant held CFO roles at Alumina, a bauxite and alumina mining business, and TPG Telecom. Grant retired as an executive last year and is now a professional director. He has been a director of Industry Funds Management (IFM) Investors since 2018 and chairs its Board investment committee. More recently, he has been appointed as the Chair of Housing Hub, and a director and chair of the audit and risk committee of Sims Metals and Megaport, both of which are ASX listed companies. Grant is based in Australia.
He is a member of Risk Management Committee. |
| Mr Antonio (Tonet) Rivera | Non-Executive Director | Nov 2024 |
Mr Rivera has over 35 years of supply chain experience, including 17 years of international leadership experience. Tonet worked for Mead Johnson Nutrition from 2002 to 2017, culminating in four years leading the global supply chain of the multinational nutrition company in the role of Senior Vice President, Global Supply Chain. In that role Tonet had responsibility for all supply chain operations globally, including manufacturing, engineering, procurement, supply planning and physical distribution. Prior to that, he served as Vice President, Supply Chain - Asia and Europe for more than a decade, with responsibility for Supply Chain operations in Europe and Asia, including owned manufacturing locations and third-party manufacturers. Since retiring from executive roles in 2017, when Mead Johnson Nutrition was acquired by Reckitt Benckiser Group plc, Tonet has worked as a supply chain consultant. He is member of Risk Management Committee.
|
| Mr Lain Jager | Non-Executive Director | Dec 2024 |
Mr Jager brings international agribusiness leadership experience to the Board through his former role as CEO of Zespri International. Zespri is the marketer of kiwifruit, distributed in more than 50 countries with revenue of NZ$4.2 billion and operating profit of NZ$230 million in FY24. Lain's nine years as CEO of Zespri International from 2008 to 2017 included the development of a global growth strategy, and increases in revenue and profitability. Since stepping down from Zespri in 2017, Lain has focused on private business interests including personal investments in a range of entrepreneurial, technology and agriculture related businesses. He is member of People Committee.
|
| Mr Jaron McVicar | Company SecretaryGeneral Counsel | Nov 2016 |
-
|
| Xiao Li | Chief Executive Officer Greater China |
-
|
|
| David Muscat | Chief Financial Officer |
-
|
|
| Edith Bailey | Chief Marketing Officer |
-
|
|
| Amanda Hart | Chief People and Culture Officer |
-
|
|
| Chopin Zhang | Chief Supply Chain Officer |
-
|
|
| Jaron McVicar | Company SecretaryGeneral Counsel |
-
|
|
| Eleanor Khor | Managing Director ANZ and Strategy |
-
|
|
| Yohan Senaratne | Managing Director International |
-
|
|
| Kevin Bush | Managing Director USA |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| HSBC Custody Nominees (Australia) Limited | 169,027,427 | 23.35% |
| Citicorp Nominees Pty Limited | 88,042,263 | 12.16% |
| J P Morgan Nominees Australia Pty Limited | 87,912,349 | 12.14% |
| BNP Paribas Nominees NZ Limited Bpss40 | 39,982,769 | 5.52% |
| Accident Compensation Corporation | 19,325,269 | 2.67% |
| TEA Custodians Limited | 18,622,668 | 2.57% |
| HSBC Nominees (New Zealand) Limited | 17,837,054 | 2.46% |
| New Zealand Superannuation Fund Nominees Limited | 13,448,326 | 1.86% |
| National Nominees Limited | 12,571,092 | 1.74% |
| New Zealand Depository Nominee | 11,915,919 | 1.65% |
| Citibank Nominees (NZ) Ltd | 10,629,794 | 1.47% |
| BNP Paribas Noms Pty Ltd | 10,287,073 | 1.42% |
| BNP Paribas Nominees Pty Ltd | 9,139,860 | 1.26% |
| Public Trust | 8,352,117 | 1.15% |
| Premier Nominees Limited | 7,744,463 | 1.07% |
| New Zealand Permanent Trustees Limited | 6,003,926 | 0.83% |
| UBS Nominees Pty Ltd | 5,936,820 | 0.82% |
| JBWere (NZ) Nominees Limited | 5,815,699 | 0.80% |
| Pt Booster Investments Nominees Limited | 5,688,233 | 0.79% |
| HSBC Custody Nominees (Australia) Limited i | 5,169,658 | 0.71% |